Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers
Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read morePhenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Read moreEnzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read moreBristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion
Read moreBiotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of
Read moreHarbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read moreThese three pharmaceutical companies should be well shielded from the adverse effects of the looming economic downturn. According to the
Read moreSuccess on the Innovation Index is important, especially now, at a time when innovation is needed more than ever. Many,
Read moreInovio Pharmaceuticals stock soared by +16.36% on Friday, as HPV drug VGX-3100 showed promise in Phase 2 Trial. Shares of
Read moreThis week, biotechnology stocks on the verge of developing a coronavirus vaccine skyrocketed as the deadly virus sent the US
Read more